← Human Trials & Peer-Reviewed Studies
Effects of curcumin supplementation on vitamin D levels in women with premenstrual syndrome and dysmenorrhea: a randomized controlled study.
Plain-language guide to PMID 35065636 (2022): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 35065636
- Journal
- BMC complementary medicine and therapies
- Year
- 2022
- Study type
- Randomized Controlled Trial
- Authors
- Arabnezhad L et al. (6 authors)
- DOI
- 10.1186/s12906-022-03515-2
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
Vitamin D has an established role in female reproduction.
There is also evidence for an association between vitamin D levels and menstrual problems such as premenstrual syndrome (PMS) and dysmenorrhea.
Who Took Part
PubMed indexes the participants as young adults, women only.
How the Study Was Run
In design terms this was a randomized and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
The comparison arm used a placebo, so changes seen with Vitamin D, K2, Magnesium and Zinc could be set against what happens without it.
Serum vitamin D levels, renal function, and liver enzymes were also measured before and after intervention.
What Was Measured
There is also evidence for an association between vitamin D levels and menstrual problems such as premenstrual syndrome (PMS) and dysmenorrhea.
This study evaluated the effects of curcumin on vitamin D levels in young women with PMS and dysmenorrhea.
Topics PubMed links to this paper include Aspartate Aminotransferases, Bilirubin, Curcumin, Dietary Supplements, Dysmenorrhea, Premenstrual Syndrome and Vitamin D.
Author keywords: Menstruation, Triglycerides and Turmeric.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2022 (BMC complementary medicine and therapies), a journal based in England.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.